InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Henrik Krook. Director active across 1 company, notably Egetis Therapeutics AB (publ). Aggregated, 2 reports have been logged. Activity tracked since 11 May 2026. The latest transaction was disclosed on 13 May 2026 (Sale). Regulator: FIN-FSA. All data is openly available.
2 of 2 declarations